GenKOre

Main Focus
In vivo gene-editing therapy

Company Stage
Pre-clinical

Technology | Tool
Hypercompact TaRGET system

Funding Stage
Series A

Location
South Korea

Website
www.genkore.com

SNIPR Biome announced today that it has secured funding from CARB-X to further advance SNIPR001 into clinical trials in haematological cancer...

Some of the best links we picked up around the internet

New findings highlight a secondary conformational checkpoint in CRISPR-Cas9 that significantly enhances its accuracy in gene editing.

American researchers have developed a novel CRISPR-based platform to identify and characterise essential nutrient transporters that support cancer...

Founded in 2018, Vivlion is a spin-out of Goethe University Frankfurt. Its mission is to provide innovative gene-editing reagents and screening...

Some of the best links we picked up around the internet

Tags